$31.80 0.84 (2.57%)
13:46 EDT PFE Stock Quote Delayed 20 Minutes
Previous Close $32.64
Market Cap 186.02B
PE Ratio 8.83
Volume (Avg. Vol.) 12.88M
Day's Range 31.53 - 32.28
52-Week Range 27.88 - 44.56
Dividend & Yield 1.36 (4.28%)
PFE Stock Predictions, Articles, and Pfizer News
- From InvestorPlace
- From the Web
The lagging healthcare sector has been building momentum and that boosted the Dow Jones Industrial Average today.
Friday's 3 big stock charts highlight 3 names looking for help from a market at all-time highs.
There's a strong case for investing in Pfizer stock. With a great deal of uncertainty in the near-term, however, some patience with PFE stock may be required.
Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.
The S&P 500 hit another new all-time high on Tuesday. Here's what happened in the stock market today to get it there.
GrubHub, Shopify, Apple, Pfizer and General Motors were our top stock trades from Tuesday. Here's a look at the charts.
Options trading was hot in Fitbit, Pfizer, and Twitter on Monday. Here’s what the data suggests moving forward.
Akcea Therapeutics (AKCA) stock is flying high on Monday following news of a $250 million deal with Pfizer (NYSE:PFE) for licensing rights.
Thanks to broader market conditions, these are seven Dow Jones stocks investors should sell now. You'll see names like CAT and GS on the list.
Based on data from Equilar 200, here are 10 companies using stock buybacks to make their CEOs rich. This list names stocks like ORCL and JPM.
PFE stock recently dropped 20% following the company's latest earnings report. As a result, Pfizer has reached extreme oversold readings that could lead to a pop in the stock.
Options trading was buzzing in Uber, Pfizer and Roku on Monday. Here are the metrics that matter moving forward.
The stock charts of Pfizer, AES and Centurylink have emerged as enticing prospects within a sea of volatility.
Q2 earnings season rolls on and Wall Street tries to not act disappointed by the early end to the latest round of U.S.-China trade talks. Thus, individual stock price action is uneven with all the focus going to a handful of names posting solid results.
Options trading was buzzing in Pfizer, Advanced Micro Devices and Apple on Tuesday. Here are the metrics that matter moving forward.
The stock charts of Southern Co, CF Industries Holdings and National-Oilwell Varco are at inflection points at the midpoint of the week.
The new company emerging from the Pfizer-Mylan deal gets former blockbusters like Lipitor and Celebrex, now generics, and the EpiPen business, which has been an object of scandal.
Navellier RatingsPowered by Portfolio Grader